Latest Posts

28 Mar 2019

FDA evaluating stents, balloons with paclitaxel coating following JAHA evaluation

A December study in The Journal of the American Heart Association by Konstantinos Katsanos, MD, of Rion, Greece, et al, reported a higher risk of death after balloons and stents used to open vessels in the legs were coated with an anti-inflammatory chemo agent called paclitaxel. “Further investigations are urgently

0
28 Mar 2019

Judge accepts Medtronic plea settling ev3 case

A federal judge in Boston accepted a plea deal from Medtronic neurovascular subsidiary ev3 in an off-label marketing case, according to court documents released at the end of January. U.S. Magistrate Judge Judith Dein granted the motion, which included the forfeiture of $6 million and an additional $11.9 million in

0
28 Mar 2019

DU STUDIES ILIOCAVAL STENT

DU STUDIES ILIOCAVAL STENT Duplex Ultrasound improves treatment of femoro-iliocaval occlusive venous disease   By Jan M. Sloves, RVT and Jose I Almeida, MD   The last two decades have witnessed a great increase in stent treatment for femoro-iliocaval occlusive venous disease. We know from previous reports that the major

0
15 Mar 2019

AVLS HOSTS Virtual Reality-BASED COURSE ON SCLEROTHERAPY

The American Vein & Lymphatic Society is offering a full day course on sclerotherapy featuring its new virtual reality hands-on training. The sclerotherapy course will be offered at 8 a.m. April 6 at the Sheraton Suites Chicago O’Hare in Rosemont, Illinois.             Register at phleboloy.org.

0
14 Mar 2019

STAINING MAY OCCUR AFTER SCLEROTHERAPY

    By Ronald F. Bush, MD, FACS and Peggy Bush, APRN Staining (hemosiderin deposition) after sclerotherapy is not infrequent. Staining results from trapped blood that occurs after sclerotherapy injections or red cell extravasation. All vessels will clot to some degree unless methods are taken to minimize clotting at the

0
SHARE

Home